Nu-Med Plus, Inc. (NUMD)

Nu-Med Plus Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0	0	0.01	0.07	0.01
Cash & Short-Term Investments	0	0	0.01	0.07	0.01
Cash Growth	-72.15%	-65.13%	-90.70%	526.94%	-93.81%
Prepaid Expenses	0.01	0.01	0.01	0.01	-
Total Current Assets	0.01	0.01	0.01	0.08	0.01
Property, Plant & Equipment	-	-	-	-	0.01
Total Assets	0.01	0.01	0.01	0.08	0.02
Accounts Payable	0.05	0.11	0.05	0.04	0.05
Accrued Expenses	0.02	0.01	0.01	0	0.09
Short-Term Debt	0.21	0.1	0.1	0.1	-
Current Portion of Leases	-	-	-	-	0.01
Total Current Liabilities	0.28	0.22	0.16	0.14	0.15
Total Liabilities	0.28	0.22	0.16	0.14	0.15
Common Stock	0.08	0.08	0.08	0.08	0.08
Additional Paid-In Capital	9.59	9.59	9.59	9.56	9.36
Retained Earnings	-9.95	-9.89	-9.82	-9.7	-9.57
Shareholders' Equity	-0.27	-0.22	-0.15	-0.06	-0.13
Total Liabilities & Equity	0.01	0.01	0.01	0.08	0.02
Total Debt	0.21	0.1	0.1	0.1	0.01
Net Cash (Debt)	-0.21	-0.1	-0.09	-0.03	0
Net Cash Growth	-	-	-	-	-97.98%
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	0.00
Filing Date Shares Outstanding	83.55	83.55	83.55	81.35	79.35
Total Common Shares Outstanding	83.55	83.55	83.55	81.35	79.35
Working Capital	-0.27	-0.22	-0.15	-0.06	-0.14
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
Tangible Book Value	-0.27	-0.22	-0.15	-0.06	-0.13
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
Machinery	-	-	-	-	0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.